← All trials
NCT02990416
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Feb 1, 2018
- Completion date
- Jun 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 63
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Angimmune LLCLead sponsor
- University of LouisvilleOverall official - principal investigator
- James Graham Brown Cancer CenterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.